tennessee - The convenient one!

The new ulrich contrast agent injector for MRI - accumulator free!

ulrich medical is an independent medium-sized company with worldwide sales of innovative products in the field of medical technology. For 25 years ulrich contrast agent injectors are reliable partners for radiological clinics and practices. They ensure optimal contrast agent injection for computer and magnetic resonance tomography.

Photo: tennessee - The convenient one!
 
In 2007 a new injector joined the product family of ulrich medical. The new convenient tennessee is accumulator free and ready for use at any time. tennessee is not only applicable for MRI but also for CT and includes the comfortable touch terminal. The injector avoids permanent time-consuming charging and handling of heavy accumulators, therefore the daily routine is not interrupted. Due to a smooth workflow the injector is absolutely dependable for both patient and user.
 
Just like the other ulrich injectors tennessee is based on the special roll pump system. Therefore a previous loading of syringes is not necessary. The injection is directly made from media containers.  Due to ulrich’s sensor technology for air detection and check valves in the patient hose of the two part hose system a safe examination is guaranteed.
 
tennessee is throughout flexible, comfortable and safe and will ease up your daily workflow!

06.12.2007

More on the subject:

Related articles

Photo

Sponsored • New Whitepaper

AI-Enabled Care Pathway: Shifting the Paradigm in Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic…

Photo

News • Prophylactic post-treatment

MRI surveillance after SCLC helps patients avoid brain irradiation

After treatment for small-cell lung cancer (SCLC), patients often undergo prophylactic radiotherapy to prevent metastases in the brain. Now, a new study shows that MRI surveillance alone is enough,…

Photo

News • Collagen-targeted protein CA

New MRI agent to earlier detect lung cancer, hidden metastases

A research team has developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches.

Subscribe to Newsletter